These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 11137871)

  • 1. Pharmacological profile of T-1032, a novel specific phosphodiesterase type 5 inhibitor, in isolated rat aorta and rabbit corpus cavernosum.
    Takagi M; Mochida H; Noto T; Yano K; Inoue H; Ikeo T; Kikkawa K
    Eur J Pharmacol; 2001 Jan; 411(1-2):161-168. PubMed ID: 11137871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sildenafil and T-1032, phosphodiesterase type 5 inhibitors, showed a different vasorelaxant property in the isolated rat aorta.
    Mochida H; Inoue H; Takagi M; Noto T; Yano K; Kikkawa K
    Eur J Pharmacol; 2002 Apr; 440(1):45-52. PubMed ID: 11959087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epimedium brevicornum Maxim extract relaxes rabbit corpus cavernosum through multitargets on nitric oxide/cyclic guanosine monophosphate signaling pathway.
    Chiu JH; Chen KK; Chien TM; Chiou WF; Chen CC; Wang JY; Lui WY; Wu CW
    Int J Impot Res; 2006; 18(4):335-42. PubMed ID: 16395327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of sildenafil, phentolamine, yohimbine and L-arginine on the rabbit corpus cavernosum.
    Sharabi FM; Daabees TT; El-Metwally MA; Senbel AM
    Fundam Clin Pharmacol; 2004 Apr; 18(2):187-94. PubMed ID: 15066133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of penile tumescence by T-1032, a new potent and specific phosphodiesterase type V inhibitor, in dogs.
    Noto T; Inoue H; Ikeo T; Kikkawa K
    J Pharmacol Exp Ther; 2000 Sep; 294(3):870-5. PubMed ID: 10945835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of NCX 4050, a new NO donor, in rabbit and human corpus cavernosum.
    Filippi S; Crescioli C; Vannelli GB; Fazzini A; Natali A; Riffaud JP; Maggi M; Ledda F
    Int J Androl; 2003 Apr; 26(2):101-8. PubMed ID: 12641828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of selective phosphodiesterase III and V inhibitors on adrenergic and non-adrenergic, non-cholinergic relaxation responses of guinea-pig pulmonary arteries.
    Tasatargil A; Sadan G; Ozdem SS
    Auton Autacoid Pharmacol; 2003 Apr; 23(2):117-24. PubMed ID: 14511071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relaxant effect of sildenafil in the rabbit basilar artery.
    Salom JB; Burguete MC; Pérez-Asensio FJ; Castelló-Ruiz M; Torregrosa G; Alborch E
    Vascul Pharmacol; 2006 Jan; 44(1):10-6. PubMed ID: 16325476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NCX-911, a novel nitric oxide-releasing PDE5 inhibitor relaxes rabbit corpus cavernosum in the absence of endogenous nitric oxide.
    Kalsi JS; Kell PD; Cellek S; Ralph DJ
    Int J Impot Res; 2004 Apr; 16(2):195-200. PubMed ID: 14961060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of a novel tetrodotoxin-resistant sodium channel in the nitrergic relaxation of corpus cavernosum from the South American rattlesnake Crotalus durissus terrificus.
    Capel RO; Mónica FZ; Porto M; Barillas S; Muscará MN; Teixeira SA; Arruda AM; Pissinatti L; Pissinatti A; Schenka AA; Antunes E; Nahoum C; Cogo JC; de Oliveira MA; De Nucci G
    J Sex Med; 2011 Jun; 8(6):1616-25. PubMed ID: 21477017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition.
    Klein T; Eltze M; Grebe T; Hatzelmann A; Kömhoff M
    Cardiovasc Res; 2007 Jul; 75(2):390-7. PubMed ID: 17383621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sildenafil relaxes rabbit clitoral corpus cavernosum.
    Vemulapalli S; Kurowski S
    Life Sci; 2000 May; 67(1):23-9. PubMed ID: 10896025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of sildenafil on corpus cavernosal smooth muscle relaxation and cyclic GMP formation in the diabetic rabbit.
    Thompson CS; Mumtaz FH; Khan MA; Wallis RM; Mikhailidis DP; Morgan RJ; Angelini GD; Jeremy JY
    Eur J Pharmacol; 2001 Aug; 425(1):57-64. PubMed ID: 11672575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide release from human corpus cavernosum induced by a purified scorpion toxin.
    Teixeira CE; de Oliveira JF; Baracat JS; Priviero FB; Okuyama CE; Rodrigues Netto N; Fregonesi A; Antunes E; De Nucci G
    Urology; 2004 Jan; 63(1):184-9. PubMed ID: 14751389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of direct relaxant effect of sildenafil, tadalafil and vardenafil on corpus cavernosum.
    Lau LC; Adaikan PG
    Eur J Pharmacol; 2006 Jul; 541(3):184-90. PubMed ID: 16777087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sildenafil citrate and a nitric oxide donating sildenafil derivative, NCX 911, on cavernosal relaxation and superoxide formation in hypercholesterolaemic rabbits.
    Shukla N; Jones R; Persad R; Angelini GD; Jeremy JY
    Eur J Pharmacol; 2005 Jul; 517(3):224-31. PubMed ID: 15963496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potent relaxant effect of resveratrol in rat corpus cavernosum and its underlying mechanisms.
    Dalaklioglu S; Ozbey G
    Int J Impot Res; 2013 Sep; 25(5):188-93. PubMed ID: 23466662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of the phosphodiesterase type 5 inhibitors sildenafil, vardenafil, and tadalafil in rat aorta.
    Teixeira CE; Priviero FB; Webb RC
    J Pharmacol Exp Ther; 2006 Feb; 316(2):654-61. PubMed ID: 16204472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sildenafil on non-adrenergic non-cholinergic neurotransmission in bovine penile small arteries.
    Simonsen U; Contreras J; García-Sacristán A; Martinez AC
    Eur J Pharmacol; 2001 Jan; 412(2):155-69. PubMed ID: 11165227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FR226807: a potent and selective phosphodiesterase type 5 inhibitor.
    Hosogai N; Hamada K; Tomita M; Nagashima A; Takahashi T; Sekizawa T; Mizutani T; Urano Y; Kuroda A; Sawada K; Ozaki T; Seki J; Goto T
    Eur J Pharmacol; 2001 Oct; 428(2):295-302. PubMed ID: 11675048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.